Castilla J, Godoy P, Domínguez Á, Martín V, Delgado-Rodríguez M, Martínez-Baz I, Baricot M, Soldevila N, Mayoral JM, Astray J, Quintana JM, Cantón R, Castro A, González-Candelas F, Alonso J, Saez M, Tamames S, Pumarola T.

Risk factors and effectiveness of preventive measures against influenza in the community.

INFLUENZA AND OTHER RESPIRATORY VIRUSES 2013. 7(2): 177-183. Nº de citas: 17

[doi:10.1111/j.1750-2659.2012.00361.x]

Yebra G, Holguín A, Pillay D, Hué S.

Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain.

INFECTION GENETICS AND EVOLUTION 2013. 14: 232-239. Nº de citas: 24

[doi:10.1016/j.meegid.2012.12.006]

Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, Biedenbach DJ, Cantón R, Paterson DL.

Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2013. 41(3): 224-228. Nº de citas: 30

[doi:10.1016/j.ijantimicag.2012.10.014]

Galán JC, González-Candelas F, Rolain JM, Cantón R.

Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the beta-lactamases world

FRONTIERS IN MICROBIOLOGY 2013. 4: 9-9. Nº de citas: 48

[doi:10.3389/fmicb.2013.00009]

Mayoral JM, Alonso J, Garín O, Herrador Z, Astray J, Baricot M, Castilla J, Cantón R, Castro A, Delgado-Rodríguez M, Ferri A, Godoy P, Gónzález-Candelas F, Martín V, Pumarola T, Quintana JM, Soldevila N, Tamames S, Domínguez A, CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain.

Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic.

Bmc Public Health 2013. 13: 118-118. Nº de citas: 14

[doi:10.1186/1471-2458-13-118]

Sánchez Valenzuela A, Lavilla Lerma L, Benomar N, Gálvez A, Pérez Pulido R, Abriouel H.

Phenotypic and Molecular Antibiotic Resistance Profile of Enterococcus faecalis and Enterococcus faecium Isolated from Different Traditional Fermented Foods

FOODBORNE PATHOGENS AND DISEASE 2013. 10(2): 143-149. Nº de citas: 31

[doi:10.1089/fpd.2012.1279]

Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G.

EUCAST expert rules in antimicrobial susceptibility testing

CLINICAL MICROBIOLOGY AND INFECTION 2013. 19(2): 141-160. Nº de citas: 340

[doi:10.1111/j.1469-0691.2011.03703.x]

Muñoz-Atienza E, Gómez-Sala B, Araújo C, Campanero C, del Campo R, Hernández PE, Herranz C, Cintas LM.

Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture

BMC MICROBIOLOGY 2013. 13: 15-15. Nº de citas: 126

[doi:10.1186/1471-2180-13-15]

Baquero F.

Epigenetics, epistasis and epidemics.

EVOLUTION MEDICINE AND PUBLIC HEALTH 2013. 2013(1): 86-88.

[doi:10.1093/emph/eot009]

Gutiérrez C, Hernández-Novoa B, Pérez-Elías MJ, Moreno AM, Holguín A, Dronda F, Casado JL, Moreno S.

Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.

HIV CLINICAL TRIALS 2013. 14(1): 10-16.

[doi:10.1310/hct1401-10]

Morrissey I, Seifert H, Canton R, Nordmann P, Stefani S, Macgowan A, Janes R, Knight D.

Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and beta-haemolytic streptococci collected from western European countries in 2011

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2013. 68(1): 164-167. Nº de citas: 24

[doi:10.1093/jac/dks344]

Glasner C, Albiger B, Buist G, Tambic Andrasevic A, Canton R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A, Walsh T, Woodford N, Donker T, Monnet DL, Grundmann H.

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.

Eurosurveillance 2013. 18(28): .

Faria-Ramos I, Espinar MJ, Rocha R, Santos-Antunes J, Rodrigues AG, Cantón R, Pina-Vaz C.

A novel flow cytometric assay for rapid detection of extended-spectrum beta-lactamases

CLINICAL MICROBIOLOGY AND INFECTION 2013. 19(1): 8-15. Nº de citas: 32

[doi:10.1111/j.1469-0691.2012.03986.x]

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A.

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

Plos One 2012. 7(12): . Nº de citas: 27

[doi:10.1371/journal.pone.0052155]

Cantón R, Bryan J.

Global antimicrobial resistance: from surveillance to stewardship. Part 2: stewardship initiatives

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2012. 10(12): 1375-1377. Nº de citas: 33

[doi:10.1586/ERI.12.140]

Bapteste E, Lopez P, Bouchard F, Baquero F, McInerney JO, Burian RM.

Evolutionary analyses of non-genealogical bonds produced by introgressive descent.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2012. 109(45): 18266-18272. Nº de citas: 58

[doi:10.1073/pnas.1206541109]

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A.

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

PEDIATRIC INFECTIOUS DISEASE JOURNAL 2012. 31(11): 213-221. Nº de citas: 15

[doi:10.1097/INF.0b013e3182678c7c]

Cantón R, Bryan J.

Global antimicrobial resistance: from surveillance to stewardship. Part 1: surveillance and risk factors for resistance.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2012. 10(11): 1269-1271.

[doi:10.1586/eri.12.120]